BioPharmSignal logoBioPharmSignal

Biotech News

Charles River Laboratories to Present at Morgan Stanley and Baird Conferences

Charles River (CRL)Charles RiverFDA / regulatory

WILMINGTON, Mass. --(BUSINESS WIRE)--Sep. 11, 2026-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at two upcoming investor conferences, including: Morgan Stanley 24 th Annual Global Healthcare Conference on Monday, September 14 th, at 10:00 a.m.

Related news

CRLCharles River2026-06-01 12:00 EST

Charles River Laboratories to Present at William Blair and Jefferies Conferences

CRLCharles River2026-03-02 13:00 EST

Charles River Laboratories to Present at TD Cowen and Barclays Conferences

View all latest news

Charles River

Preclinical Research Services Charles River Laboratories provides products and outsourced services used by pharmaceutical, biotechnology, academic and government researchers across early drug development. Research Models and Services The company supplies research models and related services used in basic research, target validation and...

Recent company news

CRLCharles River2026-09-24 12:00 EST

Charles River Highlights Refreshed Strategic Vision to Drive Profitable Growth and Long-Term Value Creation at 2026 Investor Day

CRLCharles River2026-09-17 12:00 EST

Charles River Leverages Expertise in Rapid and In Vitro Methods to Reduce Cell Banking Timelines

CRLCharles River2026-09-11 12:00 EST

Charles River Laboratories to Present at Morgan Stanley and Baird Conferences

CRLCharles River2026-09-08 12:00 EST

Charles River Modernizes Endosafe® Endotoxin Testing Cartridge Manufacturing with Fully Automated Production Suite

CRLCharles River2026-08-20 12:00 EST

Charles River Laboratories and Medigen Vaccine Biologics Corp Collaborate to Advance New Vaccine Development Programs Through Next Generation Sequencing

Stock data

Close
290.19 USD
Market cap
8.42B USD
Exchange
NYSE
Sector
Biopharma
Location
United States